|
Mr. Schlotterbeck has nearly 20 years of experience in executing corporate turnarounds of global companies, including the development of strategies to accelerate growth. Since 1986, Mr. Schlotterbeck has successfully implemented transforming strategies, which have dramatically increased value at three public companies and one subsidiary division of a public company, ranging in size from $250 million in annual sales to $600 million.
Currently, Mr. Schlotterbeck serves as the Chairman and CEO of Clinical Technologies and Services, a business segment of Cardinal Health with revenues of more than $2 billion annually, and is an officer of Cardinal Health. He is directly responsible for the segment’s patient point-of-care strategy as well as other key products and services that generate a substantive portion of Cardinal Health’s annual operating earnings.
Prior to joining Clinical Technologies and Services, Mr. Schlotterbeck was the president and CEO of ALARIS Medical Systems, a developer and marketer of products for the safe delivery of intravenous medicines, which was acquired by Cardinal Health in July 2004. During his tenure at ALARIS, the Company was named the best performing stock for all three major US exchanges. In addition Mr. Schlotterbeck was named CEO of the year for medical device companies in 2002 by Frost and Sullivan. Mr. Schlotterbeck has in-depth international experience, as well as experience in identifying acquisition targets, negotiating merger agreements, integrating acquisitions and successful divestitures.
Mr. Schlotterbeck earned a Bachelor of Sciences degree in electrical engineering from the General Motors Institute and a Masters of Science in electrical engineering from Purdue University. He has also completed the Executive Institute program at Stanford University.
Committees : Nominating, Governance and Compensation Committee
| 